| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-13 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-12 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-10 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
3e-10 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-09 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-09 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-09 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.26 |
5e-09 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-09 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
9e-09 |